<DOC>
	<DOCNO>NCT01708369</DOCNO>
	<brief_summary>The purpose study determine alcohol able affect body 's ability eliminate two commonly used medication , oseltamivir aspirin . We hypothesize drink alcohol may reduce body 's ability break two medication along many others.This could affect amount drug blood could impact well drug work whether patient side effect .</brief_summary>
	<brief_title>Alcohol Inhibits Drug Metabolism Carboxylesterases</brief_title>
	<detailed_description>Carboxylesterases enzyme metabolize grow number commonly use medication . In human , two carboxylesterases , carboxylesterase-1 ( hCE1 ) carboxylesterase-2 ( hCE2 ) , find primarily liver intestine respectively , play important role biotransformation numerous class commonly use drug contain ester group include ACE inhibitor , anticancer agent , opiate analgesic , HMG-CoA reductase inhibitor ( statin ) , CNS stimulant , antiviral medication , antiplatelet agent . Factors affect activity carboxylesterases would expect markedly alter pharmacokinetics clinical effect substrate drug . One key factor could affect catalytic activity drug interaction inhibit carboxylesterase function . The importance inhibition drug metabolism medication safety efficacy well establish drug undergo metabolism cytochrome P450 enzymes . In distinct contrast , little known potential carboxylesterases serve target metabolic inhibition mediate drug interaction . It well establish ethanol inhibitor cocaine metabolism , drug eliminate carboxylesterase hydrolysis . We propose ethanol-mediated inhibition carboxylesterases activity demonstrate cocaine metabolism occur substrate drug . This widespread implication large number drug carboxylesterase substrate . In United States , 100 million people consume ethanol make co-ingestion carboxylesterase substrate drug common occurrence . We believe prevalent drug interaction largely overlook systematically evaluate , may importantly affect disposition , safety , efficacy medication . To address gap , evaluate effect ethanol disposition oseltamivir , hCE1 substrate , aspirin , hCE2 substrate , human . Normal healthy volunteer report University Tennessee Health Science Center Clinical Research Center ( CRC ) 10 hour stay four separate day receive follow treatment random order : 1 . Oseltamivir ( Tamiflu® ) 150 mg . Subjects drink orange juice ( 10 ounce although amount may vary slightly base weight ) 15 minute . Fifteen minute drink orange juice , subject receive two ( 2 ) 75 mg capsule oseltamivir 5 ounce water . Blood sample ( 1 teaspoonful ) determine amount oseltamivir blood collect dose 0.5 , 1.0 , 1.5 , 2.0 , 3.0 , 4.0 , 6.0 , 8.0 , 10 , 24 hour hour dose . Subjects allow leave CRC 10 hour blood sample collect return follow day 24 hour sample . 2 . Oseltamivir ( Tamiflu® ) 150 mg + Ethanol . In phase , subject drink amount orange juice 15 minute ethanol ( alcohol ) add . The amount ethanol add calculated achieve blood alcohol concentration 0.08 g/dl , consider legally intoxicate . Fifteen minute drink orange juice + ethanol , subject receive two ( 2 ) 75 mg capsule oseltamivir 5 ounce water . Blood sample collect time . An additional blood sample ( 1 teaspoonful ) determine blood alcohol concentration collect 30 minute drink orange juice + ethanol . 3 . Aspirin 650 mg . Subjects drink orange juice ( 10 ounce although amount may vary slightly base weight ) 15 minute . Fifteen minute drink orange juice , take two ( 2 ) 325 mg aspirin tablet 5 oz water . Blood sample determine amount aspirin blood collect aspirin dose 10 , 20 , 30 minute dose 1.0 , 1.5 , 2.0 , 2.5 , 3.0 , 4.0 , 5.0 , 6.0 , 7.0 , 8.0 hour dose . 4 . Aspirin 650 mg + Ethanol . In phase , subject drink amount orange juice 15 minute ethanol ( alcohol ) add . The amount ethanol add calculated achieve blood alcohol concentration 0.08 g/dl , consider legally intoxicate . Fifteen minute drink orange juice + ethanol , subject take two ( 2 ) 325 mg aspirin tablet 5 ounce water . Blood sample ( 1 teaspoonful ) determine amount aspirin blood collect aspirin dose 10 , 20 , 30 minute dose 1.0 , 1.5 , 2.0 , 2.5 , 3.0 , 4.0 , 5.0 , 6.0 , 7.0 , 8.0 hour dose .</detailed_description>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Oseltamivir</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Healthy volunteer age 2145 chronic medical psychiatric condition social ethanol drinker allergy hypersensitivity oseltamivir aspirin concomitant medication treatment ( either prescription , counter , herbal , supplement vitamin coexist disease affect cardiovascular , hepatic , renal , pulmonary , hematologic , gastrointestinal function platelet count &lt; 100,000 , hematocrit &lt; 30 chronic psychiatric disorder score &gt; 2 Michigan Alcohol Screening Test ( MAST ) naive alcohol ingestion , family history alcohol dependence , history adverse response alcohol woman know pregnancy , lactation , use effective method birth control ( subject take oral contraceptive exclude ) ingestion alcohol caffeine study participation another drug study blood donation within precede week .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>human carboxylesterase-1</keyword>
	<keyword>human carboxylesterase-2</keyword>
	<keyword>alcohol</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>